Xencor, Inc.
HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN
Last updated:
Abstract:
The present invention relates to novel antigen binding domains and heterodimeric antibodies that bind Fibroblast Activation Protein (FAP).
Status:
Application
Type:
Utility
Filling date:
16 Apr 2021
Issue date:
19 Aug 2021